In The Spotlight
DDNews Cancer Research Exclusive
 
 
Recent work with nanoparticles offers a new approach to photo-thermal cancer therapies
 
(Photo credit: University of Toronto)
 
The PEARLs (Photothermal Enhancing Auto-Regulated Liposomes) were developed by Dr. Gang Zheng of the Princess Margaret Cancer Centre and University of Toronto and colleagues, who say they overcome traditional roadblocks to penetrate deeper into tumors.
 
 
NEWS
The pharma giant is gearing up to acquire Array BioPharma for $11.4 billion
 
Andrea Toell of Lonza shares how CAR T cells are transforming immuno-oncology
 
Earlier this quarter, NEC Corporation announced a $50-million Series A strategic investment in biomedical software company BostonGene
 
Arcus and Strata announce clinical development collaboration for AB122 and predictive biomarkers
 
MI Transcriptome companion diagnostic test receives FDA Breakthrough Device Designation
 
CytoDyn seeks to evaluate PRO 140 in breast cancer and NASH
 
Drilling to the core of life itself: Researchers go deep into the world of metabolomics to find new therapeutic possibilities with metabo-oncology
 
Come to Boston again, or for the first time, to get the insight on immuno-oncology
 
  
FEATURES
 
 
Glioblastoma remains a difficult cancer to treat, but the brain malignancy is seeing increasing attention in R&D
 
OPINION
Open Science approaches to the treatment of a rare childhood cancer
by Sue Cramp, Charles River
In pursuit of new options for treating childhood cancers, a new approach to drug discovery and development may be an answer

Guest Commentary: A tale of safety and consistency
by Charles River Laboratories
Drs. Ulrike Herbrand, Christopher Sucato and Alvaro Jorge Amor of Charles River Laboratories discuss the challenges of bringing antibody-drug conjugates to market

Guest Commentary: Opportunities for personalized cancer immunotherapy directed by immune-profiling
by S. Anderton and M. Millar
There are currently three main approaches to characterizing the immune landscape of solid tumors: transcriptional profiling, single-cell cytometric analyses and histology; each of these disciplines brings its own benefits and, with rapid technological advances, powerful datasets are now achievable.

 
CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2019 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.